📰 Silverstein Foundation News
Page 2 - Silverstein Foundation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Silverstein Foundation. Real-time updates on events, politics, business and more.
February 6, 2024
Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level of control armBETHESDA, Md., Feb. 06, 2024 ...
February 6, 2024
Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level of control armBETHESDA, Md., Feb. 06, 2024 ...
February 6, 2024
Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level...
October 10, 2023
SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct 10, 2023--
October 10, 2023
SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct 10, 2023--
October 10, 2023
SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct 10, 2023--
October 4, 2023
First small molecule allosteric binder discovered with Gain’s computational drug discovery platform enters clinical developmentBETHESDA, Md., Oct. 04, 2023 -- Gain Therapeutics, Inc. , a...
September 12, 2023
First drug candidate identified with Gain’s proprietary computational drug discovery platform SEE-Tx® to enter clinical development phase BETHESDA, Md., Sept. 12, 2023 ...
May 12, 2023
Successfully completed GLP toxicology studies for lead program GT-02287 in GBA1 Parkinson’s diseaseCompany is on track to submit application for start of Phase 1 clinical trial of GT-02287 to... | May 12, 2023
May 3, 2023
BETHESDA, Md., May 03, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced that Innosuisse, the... | May 3, 2023